OATP1B1 polymorphisms and torsemide pharmacokinetics and pharmacodynamics

被引:0
|
作者
Vormfelde, S. V. [1 ]
Toliat, M. R. [2 ]
Schirmer, M. [1 ]
Meineke, I. [1 ]
Nuernberg, P. [2 ]
Brockmoeller, J. [1 ]
机构
[1] Univ Gottingen, Dept Clin Pharmacol, Gottingen, Germany
[2] Univ Cologne, Cologne Ctr Genom, Cologne, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:384 / 384
页数:1
相关论文
共 50 条
  • [1] Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects
    Yun Kim
    Seonghae Yoon
    Yewon Choi
    Seo Hyun Yoon
    Joo-Youn Cho
    In-Jin Jang
    Kyung-Sang Yu
    Jae-Yong Chung
    Scientific Reports, 9
  • [2] Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects
    Kim, Yun
    Yoon, Seonghae
    Choi, Yewon
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Jang, In-Jin
    Yu, Kyung-Sang
    Chung, Jae-Yong
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [3] Therapeutic Implications of OATP1B1 Polymorphisms
    Niemi, Mikko
    DRUG METABOLISM REVIEWS, 2010, 42 : 7 - 7
  • [4] GENETIC POLYMORPHISMS OF OATP1B1 AND BCRP; IMPLICATIONS FOR INTERINDIVIDUAL DIFFERENCE OF PHARMACOKINETICS OF DRUGS
    Sugiyama, Yuichi
    Kusuhara, Hiroyuki
    DRUG METABOLISM REVIEWS, 2008, 40 : 21 - 22
  • [5] Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene
    Tina Trdan Lušin
    Bruno Stieger
    Janja Marc
    Aleš Mrhar
    Jurij Trontelj
    Andrej Zavratnik
    Barbara Ostanek
    Journal of Translational Medicine, 10
  • [6] The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele*3 independently affect torsemide pharmacokinetics and pharmacodynamics
    Vormfelde, S. V.
    Toliat, M. R.
    Schirmer, M.
    Meineke, I.
    Nuernberg, P.
    Brockmoeller, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (06) : 815 - 817
  • [7] Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene
    Lusin, Tina Trdan
    Stieger, Bruno
    Marc, Janja
    Mrhar, Ales
    Trontelj, Jurij
    Zavratnik, Andrej
    Ostanek, Barbara
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [8] FUNCTIONAL ASSESSMENT OF OATP1B1 AND BCRP POLYMORPHISMS IN AN OATP1B1/BCRP CO-EXPRESSING MODEL
    Warren, Mark
    Jahic, Mirza
    Zhang, Xuexiang
    Kaufman, Ilene
    Huang, Jane
    Huang, Yong
    DRUG METABOLISM REVIEWS, 2014, 45 : 246 - 247
  • [9] Effect of genetic polymorphisms of uptake(OATP1B1) and efflux (BCRP) transporters on the pharmacokinetics of pitavastatin
    Tian, Lei
    Jiang, Juanjuan
    Liu, Hong
    Han, Lulu
    Huang, Yiling
    Li, Yishi
    CARDIOLOGY, 2011, 120 : 26 - 27
  • [10] Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans
    Choi, J. H.
    Lee, M. G.
    Cho, J-Y
    Lee, J-E
    Kim, K. H.
    Park, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 251 - 257